The Mesothelioma Applied Research Foundation (MARF) is a non-profit organization dedicated to funding research for mesothelioma, a rare and aggressive cancer caused by asbestos exposure. Since its inception in 2000, MARF has funded numerous research projects focused on improving the diagnosis, treatment, and ultimately finding a cure for mesothelioma. Here are some of the research projects that MARF has funded:
Biomarkers for Early Detection: MARF has funded several research projects aimed at identifying biomarkers for early detection of mesothelioma. Biomarkers are substances in the body that can indicate the presence of a disease. Researchers are looking for biomarkers that can be detected through blood tests or other non-invasive methods, which could lead to earlier diagnosis and better outcomes for mesothelioma patients.
Immunotherapy: MARF has supported several studies investigating the use of immunotherapy to treat mesothelioma. Immunotherapy is a type of cancer treatment that harnesses the body’s immune system to attack cancer cells. Researchers are exploring different types of immunotherapy, including checkpoint inhibitors, CAR T-cell therapy, and vaccines, to see which may be effective for mesothelioma.
Mesothelioma Tissue Bank: MARF has established a mesothelioma tissue bank that collects and stores tissue samples from mesothelioma patients. These samples are used by researchers to study the disease at the molecular level, which can provide insights into its underlying biology and potential treatment strategies.
Clinical Trials: MARF has funded several clinical trials aimed at testing new treatments for mesothelioma. Clinical trials are research studies that test the safety and effectiveness of new treatments in humans. MARF has supported trials of chemotherapy, radiation therapy, and targeted therapies, among others.
Genetic Studies: MARF has funded studies investigating the genetic basis of mesothelioma. Researchers are looking for genetic mutations that may increase the risk of developing mesothelioma or affect its progression. Understanding the genetic underpinnings of the disease could lead to new targeted therapies.
Supportive Care: MARF has supported research into supportive care for mesothelioma patients, including pain management, symptom control, and quality of life issues. This research aims to improve the overall well-being of mesothelioma patients and their families.
Patient Registry: MARF has established a patient registry that collects information from mesothelioma patients and their families. This registry provides researchers with valuable data on the disease, including its incidence, risk factors, and treatment outcomes.
Overall, MARF has played a critical role in advancing research on mesothelioma. Its funding has supported a wide range of research projects, from basic science to clinical trials, and has helped to build a strong community of researchers dedicated to finding a cure for this devastating disease.
